powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1194014605
Danny Khalil
M.D., PH.D.
PRACTICE
MSKCC
See all providers at this practice →
Medical Oncology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 330154
Hospital
QUALITY · MIPS · 2024
Final MIPS score
75.5
Quality
60.6
Cost
73.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.02%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
114
Beneficiaries
—
Total drug cost
$801K
Distinct drugs
7
Brand share
44.7%
Top prescribed drugs
Ondansetron Hcl
23 claims
Ivosidenib
23 claims
Lipase/Protease/Amylase
17 claims
Pantoprazole Sodium
15 claims
Potassium Chloride
13 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
103
Unique beneficiaries
—
Total services
284
Distinct HCPCS
3
Medicare payment
$28K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — below median (cohort median 458).